Skip to primary navigation
Skip to main content
Skip to footer

Exopharm

Home
Partnering
Investors
About Us
Press and Resource Centre
- Articles
- Understanding Exosomes

Exopharm Ltd — Refreshing Medicine, Today

Exopharm is a world-leading exosome medicine company seeking to develop and commercialise exosomes (or EVs) as medicines, initially with our naïve EV products, Plexaris™ and Cevaris™, and ultimately with engineered EVs including Fortrexo™

Exopharm's LEAP™ Technology provides a key step in the downstream manufacturing process of isolating and purifying EVs from their sources. LEAP provides Exopharm unparalleled access to high-purity exosomes, allowing it to solve other manufacturing and characterization challenges and to bring an exosome-based medicine into human clinical trials for the first time.